1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNovel Pharmacologic and Device-based Intervention Program for Pediatrics is sponsored by National Institute of Mental Health (NIMH). This program supports research leading to the development of novel pharmacologic and device-based treatments for childhood-onset mental disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Novel Pharmacologic and Device-based Intervention Program for Pediatrics - National Institute of Mental Health (NIMH) NIH Websites Are Changing Advisory Boards and Groups Novel Pharmacologic and Device-based Intervention Program for Pediatrics This program supports research leading to the development of novel pharmacologic and device-based treatments for childhood-onset mental disorders.
Of interest is research to evaluate the molecular and circuit-base targets of these interventions, to optimize dosing, to evaluate safety and tolerance, and to evaluate the association between target engagement and the effect on symptoms or functional domains.
Also of interest are the development of reliable and stable biomarkers of pediatric approved drug and device-based interventions to provide missing information highly needed in the field on the central targets and mechanisms; indicators of treatment response or drug safety; and to biologically identify subjects that would best respond to the intervention for stratification purposes.
Related Funding Opportunity Announcements Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) Notice of Participation of NIMH in PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)" 6001 Executive Boulevard, Room 7203, MSC 9645 301-443-3563, mgrabb@mail. nih. gov
According to the current listing, eligibility includes: Organizations capable of conducting scientific research related to the development of novel pharmacologic and device-based treatments for pediatric mental disorders. Confirm the full requirements in the official notice before applying.
Novel Pharmacologic and Device-based Intervention Program for Pediatrics is funded by National Institute of Mental Health (NIMH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read articleTennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleThe April 18 executive order, ARPA-H EVIDENT initiative, and FDA priority vouchers are reshaping mental health research funding. A guide for grant seekers.
Read article